-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Downgrades Sionna Therapeutics to Underperform, Maintains Price Target to $24

Benzinga·12/01/2025 14:27:38
Listen to the news
RBC Capital analyst Brian Abrahams downgrades Sionna Therapeutics (NASDAQ:SION) from Sector Perform to Underperform and maintains the price target from $24 to $24.